Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene editing
gene editing
German biotech launches with ‘seamless’ gene editing platform built on evolving enzymes
Endpoints
Thu, 03/16/23 - 09:28 am
Seamless Therapeutics
gene editing
Novartis Drops SCD Gene Therapy Program with Intellia
BioSpace
Fri, 02/24/23 - 09:03 am
Novartis
sickle cell disease
Intellia Therapeutics
CRISPR
gene editing
Moderna's latest genomics move sees it team up with Life Edit to develop new gene editing therapies
Fierce Biotech
Wed, 02/22/23 - 09:57 am
Moderna Therapeutics
genomics
MRNA
ElevateBio
Life Edit Therapeutics
gene editing
Study: Base Editing Shows Promise In Treating Heart Disease
BioSpace
Tue, 01/17/23 - 10:28 am
gene editing
base editing
heart disease
heart damage
Vertex Leans into Gene Editing Space with Extended Arbor Pact
BioSpace
Thu, 01/12/23 - 10:41 am
Vertex Pharmaceuticals
Arbor Biotechnologies
gene editing
Here Are the Top Five Biotech Trends for 2023
NASDAQ
Mon, 12/19/22 - 11:23 am
biotech
personalized medicine
bioprinting
tissue engineering
orphan drugs
drug discovery
gene editing
CRISPR
Editas teases tiny sickle cell sample in effort to climb back into gene editing's upper echelon
Fierce Biotech
Tue, 12/6/22 - 10:34 am
Editas Medicine
sickle cell disease
gene editing
EDT-301
Do Verve's gene edits pass down to patients' children? The FDA wants to know
Fierce Biotech
Mon, 12/5/22 - 10:42 am
Verve Therapeutics
gene editing
gene therapy
FDA
VERVE-101
Ionis gets into gene editing
EP Vantage
Mon, 11/14/22 - 10:39 am
Ionis Pharmaceuticals
gene editing
Metagenomi
FDA Pauses Verve’s Trial Plan for Gene-Editing Therapy for High Cholesterol
MedCity News
Mon, 11/7/22 - 05:17 pm
Verve Therapeutics
gene editing
FDA
heterozygous familial hypercholesterolemia
VERVE-101
HeFH
Prime time for IPO as gene editing biotech goes public with $175M
Fierce Biotech
Thu, 10/20/22 - 11:26 pm
Prime Medicine
IPOs
gene editing
Editas Rumored to be in “Advanced Discussions” around Potential Sale of Oncology Assets
BioSpace
Tue, 10/18/22 - 10:13 pm
Editas Medicine
gene editing
CRISPR
M&A
oncology
Sanofi and Jennifer Doudna-Founded Scribe ink $1B CRISPR cell therapy deal
Pharma Live
Tue, 09/27/22 - 10:23 am
Sanofi
Scribe Therapeutics
CRISPR
Jennifer Doudna
gene editing
Prime Medicine becomes the next high-profile biotech to test the IPO waters
BioPharma Dive
Mon, 09/26/22 - 11:33 pm
Prime Medicine
IPOs
gene editing
Intellia's gene editing therapies both post early successes as evidence grows for CRISPR potential
Fierce Biotech
Fri, 09/16/22 - 10:53 am
Intellia Therapeutics
gene editing
NTLA-2001
ATTR amyloidosis
clinical trials
Regeneron
Beam details reasons for FDA hold on base editing cancer therapy
BioPharma Dive
Thu, 09/1/22 - 10:29 am
Beam Therapeutics
FDA
gene editing
cancer
FDA halts testing of Beam’s base editing cancer therapy
BioPharma Dive
Mon, 08/1/22 - 10:45 am
Beam Therapeutics
clinical trials
FDA
gene editing
CRISPR
Editas treats first patient in sickle cell trial as FDA lifts partial hold
BioPharma Dive
Fri, 07/29/22 - 10:03 am
Editas Medicine
clinical trials
CRISPR
gene editing
sickle cell disease
mRNA's Next Act: Cancer Vaccines and Gene Editing
BioSpace
Tue, 07/26/22 - 10:58 am
MRNA
vaccines
cancer vaccines
gene editing
CRISPR debuted 10 years ago, in a paper hardly anyone noticed. Jennifer Doudna reflects on the DNA scissors’ first decade
Stat
Tue, 06/28/22 - 10:31 am
CRISPR
gene editing
Jennifer Doudna
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »